Beijing, China

Ya Guo

This inventor holds 3 USPTO granted patents. Top assignees: Hebei Yanda Ludaopei Hospital, Synarc Research Laboratory (Beijing) Ltd.. Active years: 2024-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ya Guo. Retrieved from https://idiyas.com/inventor/ya-guo-14amuvw7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Inventor Ya Guo

Introduction

Ya Guo is a notable inventor based in Beijing, China. He has made significant contributions to the field of medical diagnostics, particularly in the detection of tumors. With a total of 3 patents, his work focuses on innovative reagent compositions that enhance the accuracy of tumor detection.

Latest Patents

Ya Guo's latest patents include a reagent composition for the detection of non-hematopoietic tumors. This invention provides a comprehensive reagent composition that includes three sets of antibodies, facilitating flow cytometry screening and diagnosis. His second patent involves a detection reagent and therapeutic target for B cell tumors after targeted therapy. This reagent composition also comprises three groups of antibodies, aimed at improving the detection of B-lymphocyte tumors.

Career Highlights

Throughout his career, Ya Guo has worked with reputable organizations such as Synarc Research Laboratory and Hebei Yanda Ludaopei Hospital. His experience in these institutions has contributed to his expertise in the field of medical diagnostics.

Collaborations

Ya Guo has collaborated with several professionals, including Hui Wang and Man Chen, who have supported his innovative endeavors.

Conclusion

Ya Guo's contributions to tumor detection through his patented inventions highlight his role as a significant figure in medical innovation. His work continues to impact the field positively, paving the way for advancements in cancer diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…